Levels and Initial Course of Serum Alanine Aminotransferase Can Predict Outcome of Patients With Budd-Chiari Syndrome

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 11, 2009, Pages 1230-1235

  Rautou, Pierre Emmanuel ^a,b   Moucari, Rami ^a,b   Cazals Hatem, Dominique ^a   Escolano, Sylvie ^c   Denié, Cécile ^d   Douarin, Ludivine ^a,b   Francoz, Claire ^a,b   Durand, François ^a,b   Ozenne, Violaine ^a,b   Imbert, Audrey ^a,b   Moreau, Richard ^a,b   Lebrec, Didier ^a,b   Plessier, Aurélie ^a,b   Valla, Dominique ^a,b  

^a BEAUJON HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c INSERM   (France)

^d Centre Hospitalier du Grand Hornu   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BUDD CHIARI SYNDROME; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LIVER FIBROSIS; LIVER ISCHEMIA; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; VELOCITY;

ADULT; ALANINE TRANSAMINASE; BUDD-CHIARI SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 72049108415     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.06.011     Document Type: Article

References (28)

1. Janssen H.L., Garcia-Pagan J.C., Elias E., et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38 (2003) 364-371
2. Dufour D.R., Lott J.A., Nolte F.S., et al. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 46 (2000) 2027-2049
3. Imbert-Bismut F., Ratziu V., Pieroni L., et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
4. ter Borg F., ten Kate F.J., Cuypers H.T., et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 351 (1998) 1914-1918
5. Czaja A.J., Wolf A.M., and Baggenstoss A.H. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology 80 (1981) 687-692
6. Maher J.J. Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 13 (2002) 31-39
7. Ramesh S., and Sanyal A.J. Evaluation and management of non-alcoholic steatohepatitis. J Hepatol 42 Suppl (2005) S2-S12
8. Polson J., and Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 41 (2005) 1179-1197
9. Tang T.J., Batts K.P., de Groen P.C., et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 35 (2001) 338-343
10. Zeitoun G., Escolano S., Hadengue A., et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 30 (1999) 84-89
11. Murad S.D., Valla D.C., de Groen P.C., et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 39 (2004) 500-508
12. Langlet P., Escolano S., Valla D., et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 39 (2003) 496-501
13. Rautou P.E., Moucari R., Escolano S., et al. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol 104 (2009) 1140-1146
14. Plessier A., Sibert A., Consigny Y., et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44 (2006) 1308-1316
15. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
16. Rossle M., Olschewski M., Siegerstetter V., et al. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 135 (2004) 394-403
17. Mahmoud A.E., Mendoza A., Meshikhes A.N., et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM 89 (1996) 37-43
18. Dilawari J.B., Bambery P., Chawla Y., et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 73 (1994) 21-36
19. Bismuth H., and Sherlock D.J. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 214 (1991) 581-589
20. Seeto R.K., Fenn B., and Rockey D.C. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109 (2000) 109-113
21. Henrion J., Schapira M., Luwaert R., et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 82 (2003) 392-406
22. Hultcrantz R., Angelin B., Einarsson K., et al. Spontaneous regression of Budd-Chiari syndrome (hepatic venous occlusion) in a young female. Acta Med Scand 221 (1987) 503-507
23. Brinson R.R., Curtis W.D., Schuman B.M., et al. Recovery from hepatic vein thrombosis (Budd-Chiari syndrome) complicating ulcerative colitis. Dig Dis Sci 33 (1988) 1615-1620
24. Cho K.J., Geisinger K.R., Shields J.J., et al. Collateral channels and histopathology in hepatic vein occlusion. AJR Am J Roentgenol 139 (1982) 703-709
25. Lefkowitch J.H., and Mendez L. Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2 (1986) 313-327
26. Henrion J. Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 63 (2000) 336-347
27. Eapen C.E., Velissaris D., Heydtmann M., et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 55 (2006) 878-884
28. Garcia-Pagan J.C., Heydtmann M., Raffa S., et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135 (2008) 808-815